Graham’s Latest Investment is a No-Brainer
March 17th, 2023
Acquires Rhythmlink, Provider of Single-Use Brain Health and Neurodiagnostic Solutions
Graham Partners, a private investment firm targeting technology-driven advanced manufacturing companies, is pleased to announce the acquisition of Rhythmlink International, LLC (“Rhythmlink”). Headquartered in Columbia, South Carolina, Rhythmlink is a designer and manufacturer of single-use brain health and neurodiagnostic solutions. Rhythmlink serves electroencephalography (“EEG”), intraoperative neuromonitoring (“IONM”), and electromyography (“EMG”) end markets through its broad disposables portfolio of imaging compatible electrodes, subdermal needles, EEG electrodes, and other neurodiagnostic products. Graham views Rhythmlink as a leader within its field, providing the important physical connection between patients and the diagnostic equipment to record or elicit neurophysiologic biopotentials.
Rhythmlink was originally founded by neurodiagnostic technicians and engineers with a goal to provide a better solution in this space, and Graham believes that the company stands to benefit from several secular tailwinds moving forward. Based on its industry research, Graham believes the increased prevalence of underlying core diseases, such as epilepsy, sleep disorders, and other emerging use cases is driving growth in the broader EEG market. Graham believes that many end users are also increasingly preferring disposable products, driven by the desire to avoid hospital-acquired infections. Additionally, Graham views disposable electrodes as typically economical and efficient, saving users considerable time, money and effort compared to reusable EEG electrodes.
Graham Partners has experience with companies offering disposable medical products through prior investments and believes it can leverage this experience in its partnership with Rhythmlink. Josh Wilson, Managing Principal at Graham Partners, said, “Graham was excited by Rhythmlink’s value proposition and differentiated offering, in addition to the company’s entrepreneurial heritage, as well as its commitment to continuous innovation. Graham is looking forward to leveraging our experience in the space and collaborating with the company and management team during our ownership.”
Headquartered in Columbia, South Carolina, Rhythmlink is a designer and manufacturer of single-use brain health and neurodiagnostic solutions. Rhythmlink serves EEG, IONM, and EMG end markets through its broad disposables portfolio of imaging compatible electrodes, subdermal needles, EEG electrodes, and other neurodiagnostic products. The company primarily sells direct to hospitals and health systems, IONM service providers, and original equipment manufacturers.
FOR FURTHER INFORMATION CONTACT:
Josh Wilson (email@example.com)
Christina Morin (firstname.lastname@example.org)
Tel: (610) 408-0500
This press release is for informational purposes and is not an offer to sell, or a solicitation of an offer to buy, securities in the United States or elsewhere. Graham Partners is not utilizing this release to provide investment or other advice, and no information disclosed therein is to be relied upon for the purpose of making investment decisions. Past performance does not guarantee future results and any transactions described are included as representative transactions and are not necessarily reflective of overall performance. It should not be assumed that any investment described herein was or will be profitable.